NeueHealth, Inc. (NYSE:NEUE) Short Interest Update

NeueHealth, Inc. (NYSE:NEUE) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 9,200 shares, a drop of 25.8% from the February 13th total of 12,400 shares. Based on an average trading volume of 38,400 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.3% of the company’s stock are sold short.

NeueHealth Stock Down 23.7 %

Shares of NeueHealth stock traded down $1.57 on Friday, reaching $5.06. The company’s stock had a trading volume of 242,231 shares, compared to its average volume of 18,768. The company has a market capitalization of $41.93 million, a P/E ratio of -0.10 and a beta of 0.56. NeueHealth has a 52-week low of $3.79 and a 52-week high of $7.66. The stock has a 50-day moving average price of $7.26 and a 200-day moving average price of $6.01.

Insiders Place Their Bets

In related news, CFO Jay Matushak sold 4,970 shares of NeueHealth stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the transaction, the chief financial officer now directly owns 17,747 shares in the company, valued at approximately $130,085.51. This trade represents a 21.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO George Lawrence Mikan III sold 16,803 shares of NeueHealth stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $4.18, for a total value of $70,236.54. Following the transaction, the chief executive officer now owns 83,029 shares of the company’s stock, valued at approximately $347,061.22. This represents a 16.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 107,470 shares of company stock valued at $723,370. 64.30% of the stock is currently owned by corporate insiders.

Institutional Trading of NeueHealth

A number of institutional investors have recently made changes to their positions in NEUE. Partners Group Holding AG acquired a new stake in shares of NeueHealth in the third quarter worth approximately $463,000. Virtu Financial LLC acquired a new stake in shares of NeueHealth in the fourth quarter worth approximately $76,000. Finally, Northern Trust Corp boosted its stake in shares of NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after acquiring an additional 13,074 shares during the last quarter. 63.88% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada cut their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.